{"id":"W4400874371","doi":"10.1101/2024.07.22.24310806","title":"LRRK2-Associated Parkinsonism With and Without <i>In Vivo</i> Evidence of Alpha-Synuclein Aggregates","year":2024,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Institute on Aging; Avid Radiopharmaceuticals; Genentech; Allergan; National Institutes of Health; H. Lundbeck A/S; Servier; Sun Pharma; Voyager Therapeutics; Neurocrine Biosciences; Biogen; Celgene; Jazz Pharmaceuticals; Verily Life Sciences; Teva Pharmaceutical Industries; Sanofi; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company","keywords":"Parkinsonism; LRRK2; Biomarker; Alpha-synuclein; Neuroscience; In vivo; Parkinson's disease; Medicine; Phenotype; Pathology; Oncology; Biology; Disease; Genetics; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004628338,0.0003584563,0.0003686631,0.0005456286,0.0004201703,0.0004773922,0.0002583872,0.0002759418,0.001331971],"category_scores_gemma":[0.001250618,0.000197388,0.0002900491,0.0003104643,0.0003096319,0.0003070359,0.0003703568,0.0002598309,0.0002288806],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002129937,"about_ca_system_score_gemma":0.0001287106,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001269077,"about_ca_topic_score_gemma":0.001457633,"domain_scores_codex":[0.999536,0.00009033378,0.00007122966,0.000184914,0.00006943486,0.00004799183],"domain_scores_gemma":[0.999035,0.0001289541,0.0005607876,0.00006959032,0.00008964467,0.0001160137],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005958154,0.00005332872,0.9958957,0.00001172733,0.00007942788,0.0005220459,0.00004980178,0.00003152603,0.001727154,0.00001875452,0.00004832518,0.000966441],"study_design_scores_gemma":[0.0000262759,0.0003957862,0.9950355,0.000006409563,0.00006236292,0.003525717,0.00009647515,0.0001810642,0.0004763542,0.00005523784,0.0001344339,0.000004498261],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994344,0.0001055977,0.00008175508,0.000008365104,0.000002004915,0.000008798833,0.0001214489,0.000002459845,0.0002350514],"genre_scores_gemma":[0.9996001,0.00002638355,0.00006041305,0.00001115931,0.000004719032,0.000006153938,0.0002047044,0.000001229962,0.00008503695],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001331971,"threshold_uncertainty_score":0.004455924,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02644470797725056,"score_gpt":0.2877741343197339,"score_spread":0.2613294263424834,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}